temozolomide has been researched along with tanespimycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, J; Dellagatta, J; Kesari, S; Kieran, MW; Kung, AL; Ramakrishna, NR; Sauvageot, CM; Stiles, CD; Weatherbee, JL; Wen, PY; Winters, SE | 1 |
| Eccles, S; Gaspar, N; Jones, C; Pacey, S; Pearson, A; Sharp, SY; Vassal, G; Walton, M; Workman, P | 1 |
| Hirose, Y; Kawase, T; Ohba, S; Yazaki, T; Yoshida, K | 1 |
3 other study(ies) available for temozolomide and tanespimycin
| Article | Year |
|---|---|
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Benzoquinones; Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Therapy, Combination; ErbB Receptors; Glioma; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Nude; Mice, SCID; PTEN Phosphohydrolase; Radiation Tolerance; Stem Cells; Temozolomide; Tumor Suppressor Protein p53 | 2009 |
Acquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzoquinones; Cell Line, Tumor; Dacarbazine; Drug Resistance, Neoplasm; Female; Glioblastoma; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; NAD(P)H Dehydrogenase (Quinone); RNA, Messenger; Temozolomide | 2009 |
Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Topics: Animals; Annexin A5; Antineoplastic Agents; Apoptosis; Benzoquinones; Carmustine; Cell Cycle; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Therapy, Combination; Female; Glioma; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Temozolomide | 2010 |